Brian joined Akoya Biosciences in July 2017 serving as the CEO, bringing his experience as a 25-year veteran of the life sciences market with a proven track record of building and commercializing products and services for both the research and clinical markets. Most recently, he drove corporate and business development at Cellular Dynamics International (acquired by FUJIFilm) with a focus on the development and partnering of their four cell therapy programs. Prior to that, Brian built and ran commercial organizations at 10X Genomics, Thermo Fisher Scientific / Life Technologies, Affymetrix (IPO, acquired by Thermo Fisher) and Ingenuity Systems (acquired by Qiagen). He came to Thermo Fisher and Life Technologies through their acquisition of Ion Torrent in 2010 where he was an early employee and built the global commercial organization.
Clinical Dx showcase:
Our mission is to bring context to the world of biology and human health through the power of spatial phenotyping. Akoya’s single-cell imaging solutions phenotype cells with spatial context to visualize how they organize and interact to influence disease progression and treatment response
Scaling Up Single-Cell Spatial Biology Studies: From Basic Discovery
Spatial biology has rapidly emerged as the next frontier in biological research. Single-cell imaging of whole tissue can be used to phenotype cells with spatial context to visualize how they organize and interact to influence disease progression and treatment response.
Sequencing technologies are continuously improving, making it easier to obtain more in-depth molecular information than ever before. Emerging single-cell multi-omics sequencing technologies allow the capture of multiple modalities from a cell, including its epigenome, transcriptome, epitranscriptome, and proteome. This allows research into the heterogeneity of many biological mechanisms, and insights into complex molecular mechanisms that underpin disease.